Procter & Gamble (NYSE: PG ) is expected to report Q4 earnings on Aug. 3. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Procter & Gamble's revenues will drop -2.8% and EPS will wane -8.3%.
The average estimate for revenue is $20.27 billion. On the bottom line, the average EPS estimate is $0.77.
Last quarter, Procter & Gamble reported revenue of $20.19 billion. GAAP reported sales were 1.5% higher than the prior-year quarter's $19.89 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.94. GAAP EPS of $0.82 for Q3 were 15% lower than the prior-year quarter's $0.96 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 49.3%, 150 basis points worse than the prior-year quarter. Operating margin was 19.0%, 40 basis points better than the prior-year quarter. Net margin was 11.9%, 250 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $83.88 billion. The average EPS estimate is $3.81.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 7,456 members rating the stock outperform, and 243 members rating it underperform. Among 1,929 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 1,891 give Procter & Gamble a green thumbs-up, and 38 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Procter & Gamble is outperform, with an average price target of $71.96.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Procter & Gamble. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Procter & Gamble to My Watchlist.